advertisement

---

Garway-Heath DF 15

Showing records 1 to 15 | Display all abstracts from Garway-Heath DF

91853 OCT Signal Enhancement with Deep Learning
Lazaridis G
Ophthalmology. Glaucoma 2021; 4: 295-304

---

91168 Risk Factors for Visual Field Deterioration in the United Kingdom Glaucoma Treatment Study
Founti P
Ophthalmology 2020; 127: 1642-1651

---

91853 OCT Signal Enhancement with Deep Learning
Lazaridis G; Lorenzi M
Ophthalmology. Glaucoma 2021; 4: 295-304

---

91168 Risk Factors for Visual Field Deterioration in the United Kingdom Glaucoma Treatment Study
Bunce C
Ophthalmology 2020; 127: 1642-1651

---

91853 OCT Signal Enhancement with Deep Learning
Lorenzi M
Ophthalmology. Glaucoma 2021; 4: 295-304

---

91168 Risk Factors for Visual Field Deterioration in the United Kingdom Glaucoma Treatment Study
Khawaja AP
Ophthalmology 2020; 127: 1642-1651

---

91853 OCT Signal Enhancement with Deep Learning
Mohamed-Noriega J
Ophthalmology. Glaucoma 2021; 4: 295-304

---

91168 Risk Factors for Visual Field Deterioration in the United Kingdom Glaucoma Treatment Study
Doré CJ
Ophthalmology 2020; 127: 1642-1651

---

91853 OCT Signal Enhancement with Deep Learning
Aguilar-Munoa S
Ophthalmology. Glaucoma 2021; 4: 295-304

---

91168 Risk Factors for Visual Field Deterioration in the United Kingdom Glaucoma Treatment Study
Mohamed-Noriega J
Ophthalmology 2020; 127: 1642-1651

---

91853 OCT Signal Enhancement with Deep Learning
Suzuki K
Ophthalmology. Glaucoma 2021; 4: 295-304

---

91168 Risk Factors for Visual Field Deterioration in the United Kingdom Glaucoma Treatment Study
Garway-Heath DF
Ophthalmology 2020; 127: 1642-1651

---

91853 OCT Signal Enhancement with Deep Learning
Nomoto H; Ourselin S
Ophthalmology. Glaucoma 2021; 4: 295-304

---

91168 Risk Factors for Visual Field Deterioration in the United Kingdom Glaucoma Treatment Study

Ophthalmology 2020; 127: 1642-1651

---

91853 OCT Signal Enhancement with Deep Learning
Ourselin S; Garway-Heath DF;
Ophthalmology. Glaucoma 2021; 4: 295-304

---